A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery
Clinical trial NCT06391931 · COMPLETED
Trial details
- NCT number
- NCT06391931
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-07
- Primary completion
- 2024-11-06
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.